WuXi using Thermo Fisher to equip 28,000L single-use site in China

By Dan Stanton contact

- Last updated on GMT

WuXi using Thermo Fisher to equip 28,000L single-use site in China

Related tags: Thermo fisher, Thermo fisher scientific, Thermo electron

A WuXi Biologics facility tipped to be the world’s largest single-use mammalian cell culture site will be equipped with disposable systems from Thermo Fisher.

Construction on the $150m (€138m) facility in Wuxi City, China, began in 2015​, and the contract manufacturing organisation (CMO) has said it will be the largest mammalian cell culture manufacturing site in the world based on disposable equipment when it opens this year.

And the planned 28,000L of bioreactor capacity is being supplied by Thermo Fisher through fourteen 2,000L single-use systems, Dirk Tillich – VP of Global Sales at Thermo Fisher Scientific owned​ company Finesse Solutions – told delegates at last month’s BPI European Summit in Amsterdam.

As well as the clinical and commercial scale vessels, Thermo Fisher has supplied ten single-use bioreactors as seed vessels at the site, along with glass vessels and perfusion equipment at an on-site plant which opened its doors last year​ as the first phase in the $150m project.

The WuXi plant – located about 100km west of Shanghai – will manufacture a recombinant soluble LAG-3 protein on behalf of Prima Biomed​ among the deals already announced by the CMO.

Related news

Show more

Related products

show more

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Related suppliers

Follow us


View more